← Back to Search

Crisis Line Support for Suicide Prevention in Alcoholism

N/A
Recruiting
Led By Mark Ilgen, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients who do not understand English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Summary

This trial is testing whether a therapy session about thoughts and perceptions of the National Suicide Prevention Lifeline could help people who have experienced a suicidal crisis.

Who is the study for?
This trial is for individuals with a probable alcohol use disorder in the past year, indicated by an AUDIT score of 16 or more. Participants must have attempted suicide within the last year or had suicidal thoughts recently, as shown by certain scores on the Beck scales.
What is being tested?
The study is testing whether therapy sessions discussing perceptions about using the National Suicide Prevention Lifeline can benefit those who've faced a suicidal crisis and have issues with alcohol.
What are the potential side effects?
Since this trial involves therapy sessions rather than medication, traditional side effects are not expected. However, participants may experience emotional distress when discussing sensitive topics like suicide.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not understand English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Crisis line utilization
Secondary study objectives
Suicidal behavior

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Crisis Line Facilitation (CLF)Experimental Treatment1 Intervention
This single-session intervention addresses the individuals' perceived barriers and facilitators of crisis line use during periods of suicidal crisis.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
Participants randomized to the EUC condition will receive a brochure (in-person, via email, or via text message) with the NSP Lifeline and a list of outpatient mental health and substance use resources and encouraged to schedule an appointment with a clinical provider if they would like to discuss any current or past symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Crisis Line Facilitation (CLF)
2016
N/A
~310

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,833 Previous Clinical Trials
6,422,628 Total Patients Enrolled
9 Trials studying Alcoholism
6,961 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
823 Previous Clinical Trials
1,160,806 Total Patients Enrolled
432 Trials studying Alcoholism
777,967 Patients Enrolled for Alcoholism
Mark Ilgen, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
538 Total Patients Enrolled

Media Library

Crisis Line Facilitation (CLF) Clinical Trial Eligibility Overview. Trial Name: NCT04488055 — N/A
Alcoholism Research Study Groups: Crisis Line Facilitation (CLF), Enhanced Usual Care (EUC)
Alcoholism Clinical Trial 2023: Crisis Line Facilitation (CLF) Highlights & Side Effects. Trial Name: NCT04488055 — N/A
Crisis Line Facilitation (CLF) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04488055 — N/A
~73 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top